NSEShareholders meeting24 Aug 2026 · 24 Aug 2026, 10:55 pm

Shareholders meeting

BALAXI PHARMACEUTICALS LIMITED · BALAXI

✦ AI Summary

Balaxi Pharmaceuticals Limited held its 83rd Annual General Meeting on August 24, 2026, through video conferencing. The meeting was attended by the Chairman, Managing Director, Independent Directors, Key Managerial Personnel, Statutory Auditors, and Secretarial Auditors. The meeting discussed various resolutions, including the Statutory Auditors' Reports and the Secretarial Audit Report, and voted on several items through remote e-voting and e-voting at the meeting.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Proceedings of the 83rd Annual General Meeting held on 24th August, 2026

Attachments (1)

📄

BALAXI_24082026225525_NSE_Announcement_Proceedings_of_AGM_24082026.pdf

pdf

Download →
View document text
Date: 24th August, 2026 Listing Department, National Stock Exchange of India Limited Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 NSE Symbol: BALAXI Subject: Summary of proceedings of the 83rd Annual General Meeting of the Company held on Monday, 24th August, 2026 Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the 83rd Annual General Meeting (“AGM”) of the Members of the Company held on Monday, 24th August, 2026, at 11.00 A.M. (IST) through Video Conferencing (“VC”)/ Other Audio Visual Means (“OAVM”), the deemed venue of the meeting being the Registered Office of the Company. The proceedings of the AGM will also be hosted on the Company’s website at www.balaxipharma.in . This is for your information and records. Yours faithfully, For Balaxi Pharmaceuticals Limited Aman Purohit (Company Secretary & Compliance Officer) Membership No.: A59345 Encl: As above SUMMARY OF PROCEEDINGS OF THE 83RD ANNUAL GENERAL MEETING OF BALAXI PHARMACEUTICALS LIMITED The 83rd Annual General Meeting (“AGM”) of the members of Balaxi Pharmaceuticals Limited (“the Company”) was held on Monday, 24th August, 2026, at 11:00 A.M. (IST) through Video Conferencing (“VC”)/ Other Audio Visual Means (“OAVM”), in compliance with General Circulars issued by the Ministry of Corporate Affairs (“MCA”), the Securities and Exchange Board of India (“SEBI”) and applicable provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Ashish Maheshwari, Chairman of the Board and Managing Director (DIN: 01575984), took the chair and conducted the proceedings of the AGM. The following Directors attended the AGM through VC/OAVM from their respective locations: Sl. Name of the Director Designation 1. Mr. Ashish Maheshwari Chairman of the Board and Managing Director; Chairperson of Risk Management Committee. 2. Mr. Kunal Mahendra Independent Director and Chairman of Audit Bhakta Committee, Stakeholders Relationship Committee and Nomination and Remuneration Committee. 3. Mr. Mangina Srinivas Rao Independent Director 4. Ms. Akshita Ostwal Independent Director The following KMPs, Auditors and Invitees attended the AGM through VC/OAVM from their respective locations: Sl. Name Designation 1. Mr. Amol Anand Mantri Chief Financial officer. 2. Mr. Aman Purohit Company Secretary & Compliance Officer. 3. Mr. Pranav Maheshwari SVP - Business Development. 4. Mr. Sunny Purohit Vice President & Chief of Staff (MD’s office). 5. Mr. A Krishna Rao Partner, M/s. P. Murali & Co., Chartered Accountants, Statutory Auditors. 6. Mr. Yogindunath S Scrutinizer & Designated Partner, BVR & Associates Company Secretaries LLP, Secretarial Auditors. Mr. Aman Purohit, Company Secretary and Compliance Officer, welcomed the members to the AGM. As requisite quorum was present, with the permission of the Chairman, he called the meeting to order. He then introduced the members of the Board of Directors, KMPs, members from the Senior Management, the representatives of the Statutory Auditor, representative of the Secretarial Auditor of the Company and the Scrutinizer for the meeting. Mr. Aman Purohit, Company Secretary and Compliance Officer, informed the members that Register of Directors and Key Managerial Personnel and their shareholding, the Register of Contracts in which Directors are interested, as well as any other documents that are mandated to be made available for inspection by the members in accordance with the Act, were available for inspection electronically. Members, if interested, in inspecting the same, were requested to send an email to secretarial@balaxi.in. He also informed that as the AGM was conducted through VC/ OAVM, the facility for appointment of proxies by the members is not applicable. He further informed the members that: a) The Company had provided remote e-voting facility to the members to exercise their vote in respect of business proposed in the notice of AGM through National Securities Depository Limited (“NDSL”). The remote e-voting commenced on Friday, 21st August, 2026,, at 09:00 A.M. (IST) and ended on Sunday, 23rd August, 2026, at 05:00 P.M. (IST). b) The Members who had not exercised their vote through remote e-voting were requested to cast their vote during the meeting. c) BVR & Associates Company Secretaries LLP were appointed as the Scrutinizer for remote e-voting and e-voting done during the AGM. He then requested the Chairman to address the members. Chairman welcomed and addressed the Members. Mr. Aman Purohit, Company Secretary and Compliance Officer, with the concurrence of all the members present informed that the notice convening the 83rd AGM of the Company was taken as read and tabled all resolutions as per the notice of 83rd AGM for e-voting at the meeting. He informed the members that the Statutory Auditors’ Reports for the financial year ended 31st March, 2026, does not contain any qualification, observation, comment or other remark, and in accordance with the provisions of the Act, the said report(s) were taken as read. Further, he also informed that there were no qualifications, observations or comments or other remarks in the Secretarial Audit Report that has any material adverse effect on the functioning of the Company and in accordance with the provisions of the Act, the Secretarial Audit Report was taken as read. Thereafter, Members who had registered as speakers were invited one by one to pose their views/remarks or queries. Mr. Ashish Maheshwari, Chairman, addressed the queries of the members raised during the meeting. The following items were put to vote through remote e-voting and e-voting at the AGM: Sno. Resolutions Type of Resolution Ordinary Business(es): 1. Adoption of Audited Standalone Financial Statements Ordinary 2. Adoption of Audited Consolidated Financial Statements Ordinary 3. Re-appointment of Mrs. Minoshi Maheshwari (DIN: Ordinary 01575975) as a Director, liable to retire by rotation. Special Business: 4. Re-appointment of Ms. Akshita Ostwal (DIN: 10026552), Special as an Independent Director of the Company. Chairman thanked the members for joining the meeting through VC/ OAVM. He once again requested members who have not exercised their vote through remote e-voting to cast their vote through e-voting facility which will remain open for 15 minutes after the conclusion of the AGM. The meeting concluded at 11:55 A.M. (IST) (including 15 minutes provided for evoting after the AGM). This is for your information and records. Yours faithfully, For Balaxi Pharmaceuticals Limited Aman Purohit (Company Secretary and Compliance Officer) Membership No.: A59345